Some researchers show that overexpression of ENTPD5 affects the growth of many tumors, such as gliomablastoma [20], breast cancer [21], cervical cancer [22], testicular germ cell tumor [23], and laryngeal neoplasia [24]. Here, ENTPD5 is linked to breast carcinoma.